Biotechnology · Healthcare
Board Member
2025-11-10–present
Board Member
Damora Therapeutics, Inc. (DMRA)Equibles does not estimate personal net worth.
Get an email with a short summary when Damora Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get DMRA alertsChris Cain is recorded as Board Member at Damora Therapeutics, Inc. (DMRA) since November 10, 2025. Damora Therapeutics, Inc. reported in an 8-K filed November 10, 2025 that Chris Cain was appointed Board, effective November 10, 2025. Damora Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Damora Therapeutics, Inc. includes Jennifer Jarrett (CEO and Board Member), Sherwin Sattarzadeh (CEO and COO), Peter Harwin (Chairman and Board Member) and 7 others.
“Peter Harwin, Chris Cain, Ph.D., and Julianne Bruno were appointed to the Board as directors.”
2025-11-10–present
Biotechnology · Healthcare
Board Member
2025-11-10–present